APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gabapentin

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.

Selected research

Market Structure

Global Gabapentin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025197 pages

Choose your research edition.

Industry ResearchGabapentin Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Gabapentin Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Gabapentin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gabapentin Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Gabapentin Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.

Global Gabapentin key players include Novartis, TEVA, Mylan, Pfizer, etc. Global top four manufacturers hold a share about 20%.

North America is the largest market, with a share over 30%, followed by Asia-Pacific, and Europe, both have a share about 50 percent.

Read the full market overview

In terms of product, Capsule is the largest segment, with a share about 55%. And in terms of application, the largest application is Epilepsy, followed by Neuropathic Pain, Restless Legs Syndrome, etc.

This report provides an overview of the global Gabapentin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gabapentin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gabapentin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gabapentin market size, projected growth trends, production technologies, key applications, and end-use industries.

Gabapentin Segment by Company

Pfizer

Assertio Therapeutics

TEVA

Mylan

Arbor Pharma

Novartis

Apotex

Sun Pharmaceutical

Aurobindo Pharma

Intas

Amneal

Marksans Pharma

Glenmark

Alkem

Jiangsu Enhua

Jiangsu Hengrui

Sailike

Gabapentin Segment by Type

Capsule

Tablet

Gabapentin Segment by Application

Epilepsy

Neuropathic Pain

Restless Legs Syndrome

Others

Gabapentin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gabapentin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gabapentin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gabapentin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gabapentin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gabapentin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Gabapentin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Gabapentin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Gabapentin Industry Trends Table 2. Gabapentin Industry Drivers Table 3. Gabapentin Industry Opportunities and Challenges Table 4. Gabapentin Industry Restraints Table 5. Global Gabapentin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Gabapentin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Gabapentin Sales by Manufacturers (M Unit) & (2021-2026) Table 8. Global Gabapentin Sales Market Share by Manufacturers Table 9. Global Gabapentin Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Gabapentin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Gabapentin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Gabapentin Manufacturers, Product Type & Application Table 13. Global Gabapentin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Gabapentin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Capsule Table 17. Major Manufacturers of Tablet Table 18. Global Gabapentin Sales by Type 2021 VS 2025 VS 2032 (M Unit) Table 19. Global Gabapentin Sales by Type (2021-2026) & (M Unit) Table 20. Global Gabapentin Sales by Type (2027-2032) & (M Unit) Table 21. Global Gabapentin Sales Market Share by Type (2021-2026) Table 22. Global Gabapentin Sales Market Share by Type (2027-2032) Table 23. Global Gabapentin Revenue by Type 2021 VS 2025 VS 2032 (M Unit) Table 24. Global Gabapentin Revenue by Type (2021-2026) & (M Unit) Table 25. Global Gabapentin Revenue by Type (2027-2032) & (M Unit) Table 26. Global Gabapentin Revenue Market Share by Type (2021-2026) Table 27. Global Gabapentin Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Epilepsy Table 29. Major Manufacturers of Neuropathic Pain Table 30. Major Manufacturers of Restless Legs Syndrome Table 31. Major Manufacturers of Others Table 32. Global Gabapentin Sales by Application 2021 VS 2025 VS 2032 (M Unit) Table 33. Global Gabapentin Sales by Application (2021-2026) & (M Unit) Table 34. Global Gabapentin Sales by Application (2027-2032) & (M Unit) Table 35. Global Gabapentin Sales Market Share by Application (2021-2026) Table 36. Global Gabapentin Sales Market Share by Application (2027-2032) Table 37. Global Gabapentin Revenue by Application 2021 VS 2025 VS 2032 (M Unit) Table 38. Global Gabapentin Revenue by Application (2021-2026) & (M Unit) Table 39. Global Gabapentin Revenue by Application (2027-2032) & (M Unit) Table 40. Global Gabapentin Revenue Market Share by Application (2021-2026) Table 41. Global Gabapentin Revenue Market Share by Application (2027-2032) Table 42. Global Gabapentin Sales by Region: 2021 VS 2025 VS 2032 (M Unit) Table 43. Global Gabapentin Sales by Region (2021-2026) & (M Unit) Table 44. Global Gabapentin Sales Market Share by Region (2021-2026) Table 45. Global Gabapentin Sales Forecasted by Region (2027-2032) & (M Unit) Table 46. Global Gabapentin Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Gabapentin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Unit) Table 48. North America Gabapentin Sales by Country (2021-2026) & (M Unit) Table 49. North America Gabapentin Sales by Country (2027-2032) & (M Unit) Table 50. Europe Gabapentin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Unit) Table 51. Europe Gabapentin Sales by Country (2021-2026) & (M Unit) Table 52. Europe Gabapentin Sales by Country (2027-2032) & (M Unit) Table 53. Asia Pacific Gabapentin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Unit) Table 54. Asia Pacific Gabapentin Sales by Country (2021-2026) & (M Unit) Table 55. Asia Pacific Gabapentin Sales by Country (2027-2032) & (M Unit) Table 56. South America, Middle East and Africa Gabapentin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Unit) Table 57. South America, Middle East and Africa Gabapentin Sales by Country (2021-2026) & (M Unit) Table 58. South America, Middle East and Africa Gabapentin Sales by Country (2027-2032) & (M Unit) Table 59. Global Gabapentin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Gabapentin Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Gabapentin Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Gabapentin Revenue Market Share by Region (2021-2026) Table 63. Global Gabapentin Revenue Market Share by Region (2027-2032) Table 64. Pfizer Company Information Table 65. Pfizer Business Overview Table 66. Pfizer Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Pfizer Gabapentin Product Portfolio Table 68. Pfizer Recent Development Table 69. Assertio Therapeutics Company Information Table 70. Assertio Therapeutics Business Overview Table 71. Assertio Therapeutics Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Assertio Therapeutics Gabapentin Product Portfolio Table 73. Assertio Therapeutics Recent Development Table 74. TEVA Company Information Table 75. TEVA Business Overview Table 76. TEVA Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. TEVA Gabapentin Product Portfolio Table 78. TEVA Recent Development Table 79. Mylan Company Information Table 80. Mylan Business Overview Table 81. Mylan Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Mylan Gabapentin Product Portfolio Table 83. Mylan Recent Development Table 84. Arbor Pharma Company Information Table 85. Arbor Pharma Business Overview Table 86. Arbor Pharma Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Arbor Pharma Gabapentin Product Portfolio Table 88. Arbor Pharma Recent Development Table 89. Novartis Company Information Table 90. Novartis Business Overview Table 91. Novartis Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Novartis Gabapentin Product Portfolio Table 93. Novartis Recent Development Table 94. Apotex Company Information Table 95. Apotex Business Overview Table 96. Apotex Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Apotex Gabapentin Product Portfolio Table 98. Apotex Recent Development Table 99. Sun Pharmaceutical Company Information Table 100. Sun Pharmaceutical Business Overview Table 101. Sun Pharmaceutical Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Sun Pharmaceutical Gabapentin Product Portfolio Table 103. Sun Pharmaceutical Recent Development Table 104. Aurobindo Pharma Company Information Table 105. Aurobindo Pharma Business Overview Table 106. Aurobindo Pharma Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Aurobindo Pharma Gabapentin Product Portfolio Table 108. Aurobindo Pharma Recent Development Table 109. Intas Company Information Table 110. Intas Business Overview Table 111. Intas Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Intas Gabapentin Product Portfolio Table 113. Intas Recent Development Table 114. Amneal Company Information Table 115. Amneal Business Overview Table 116. Amneal Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Amneal Gabapentin Product Portfolio Table 118. Amneal Recent Development Table 119. Marksans Pharma Company Information Table 120. Marksans Pharma Business Overview Table 121. Marksans Pharma Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Marksans Pharma Gabapentin Product Portfolio Table 123. Marksans Pharma Recent Development Table 124. Glenmark Company Information Table 125. Glenmark Business Overview Table 126. Glenmark Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Glenmark Gabapentin Product Portfolio Table 128. Glenmark Recent Development Table 129. Alkem Company Information Table 130. Alkem Business Overview Table 131. Alkem Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Alkem Gabapentin Product Portfolio Table 133. Alkem Recent Development Table 134. Jiangsu Enhua Company Information Table 135. Jiangsu Enhua Business Overview Table 136. Jiangsu Enhua Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Jiangsu Enhua Gabapentin Product Portfolio Table 138. Jiangsu Enhua Recent Development Table 139. Jiangsu Hengrui Company Information Table 140. Jiangsu Hengrui Business Overview Table 141. Jiangsu Hengrui Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Jiangsu Hengrui Gabapentin Product Portfolio Table 143. Jiangsu Hengrui Recent Development Table 144. Sailike Company Information Table 145. Sailike Business Overview Table 146. Sailike Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Sailike Gabapentin Product Portfolio Table 148. Sailike Recent Development Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Gabapentin Distributors List Table 152. Gabapentin Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Gabapentin Product Image Figure 2. Global Gabapentin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gabapentin Market Size (2021-2032) & (US$ Million) Figure 4. Global Gabapentin Sales (2021-2032) & (M Unit) Figure 5. Global Gabapentin Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Gabapentin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Capsule Image Figure 9. Tablet Image Figure 10. Global Gabapentin Sales by Type (2021 VS 2025 VS 2032) & (M Unit) Figure 11. Global Gabapentin Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Gabapentin Sales Market Share by Type (2021-2032) Figure 13. Global Gabapentin Revenue by Type (2021 VS 2025 VS 2032) & (M Unit) Figure 14. Global Gabapentin Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Gabapentin Revenue Market Share by Type (2021-2032) Figure 16. Epilepsy Image Figure 17. Neuropathic Pain Image Figure 18. Restless Legs Syndrome Image Figure 19. Others Image Figure 20. Global Gabapentin Sales by Application (2021 VS 2025 VS 2032) & (M Unit) Figure 21. Global Gabapentin Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Gabapentin Sales Market Share by Application (2021-2032) Figure 23. Global Gabapentin Revenue by Application (2021 VS 2025 VS 2032) & (M Unit) Figure 24. Global Gabapentin Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Gabapentin Revenue Market Share by Application (2021-2032) Figure 26. North America Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 27. North America Gabapentin Sales Market Share by Country (2021-2032) Figure 28. U.S. Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 29. Canada Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 30. Mexico Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 31. Europe Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 32. Europe Gabapentin Sales Market Share by Country (2021-2032) Figure 33. Germany Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 34. France Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 35. U.K. Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 36. Italy Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 37. Netherlands Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 38. Asia Pacific Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 39. Asia Pacific Gabapentin Sales Market Share by Country (2021-2032) Figure 40. China Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 41. Japan Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 42. South Korea Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 43. Southeast Asia Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 44. India Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 45. Australia Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 46. South America, Middle East and Africa Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 47. South America, Middle East and Africa Gabapentin Sales Market Share by Country (2021-2032) Figure 48. Brazil Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 49. South Africa Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 50. Saudi Arabia Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 51. Turkey Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 52. Argentina Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 53. UAE Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 54. Egypt Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 55. Chile Gabapentin Sales and Growth Rate (2021-2032) & (M Unit) Figure 56. Global Gabapentin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Gabapentin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Gabapentin Revenue (2021-2032) & (US$ Million) Figure 59. North America Gabapentin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Gabapentin Revenue (2021-2032) & (US$ Million) Figure 61. Europe Gabapentin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Gabapentin Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Gabapentin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Gabapentin Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Gabapentin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Gabapentin Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Gabapentin Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Tablet
Applications
  • Epilepsy
  • Neuropathic Pain
  • Restless Legs Syndrome
  • Others
Companies covered
  • Pfizer
  • Assertio Therapeutics
  • TEVA
  • Mylan
  • Arbor Pharma
  • Novartis
  • Apotex
  • Sun Pharmaceutical
  • Aurobindo Pharma
  • Intas
  • Amneal
  • Marksans Pharma
  • Glenmark
  • Alkem
  • Jiangsu Enhua
  • Jiangsu Hengrui
  • Sailike

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gabapentin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gabapentin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Gabapentin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Gabapentin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Gabapentin Market Dynamics
  1. 2.1 Gabapentin Industry Trends
  2. 2.2 Gabapentin Industry Drivers
  3. 2.3 Gabapentin Industry Opportunities and Challenges
  4. 2.4 Gabapentin Industry Restraints
3 Gabapentin Market by Manufacturers
  1. 3.1 Global Gabapentin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Gabapentin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Gabapentin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Gabapentin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gabapentin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Gabapentin Manufacturers, Product Type & Application
  7. 3.7 Global Gabapentin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gabapentin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gabapentin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gabapentin Tier 1, Tier 2, and Tier 3
4 Gabapentin Market by Type
  1. 4.1 Gabapentin Type Introduction
  2. 4.1.1 Capsule
  3. 4.1.2 Tablet
  4. 4.2 Global Gabapentin Sales by Type
  5. 4.2.1 Global Gabapentin Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Gabapentin Sales by Type (2021-2032)
  7. 4.2.3 Global Gabapentin Sales Market Share by Type (2021-2032)
  8. 4.3 Global Gabapentin Revenue by Type
  9. 4.3.1 Global Gabapentin Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Gabapentin Revenue by Type (2021-2032)
  11. 4.3.3 Global Gabapentin Revenue Market Share by Type (2021-2032)
5 Gabapentin Market by Application
  1. 5.1 Gabapentin Application Introduction
  2. 5.1.1 Epilepsy
  3. 5.1.2 Neuropathic Pain
  4. 5.1.3 Restless Legs Syndrome
  5. 5.1.4 Others
  6. 5.2 Global Gabapentin Sales by Application
  7. 5.2.1 Global Gabapentin Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Gabapentin Sales by Application (2021-2032)
  9. 5.2.3 Global Gabapentin Sales Market Share by Application (2021-2032)
  10. 5.3 Global Gabapentin Revenue by Application
  11. 5.3.1 Global Gabapentin Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Gabapentin Revenue by Application (2021-2032)
  13. 5.3.3 Global Gabapentin Revenue Market Share by Application (2021-2032)
6 Global Gabapentin Sales by Region
  1. 6.1 Global Gabapentin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gabapentin Sales by Region (2021-2032)
  3. 6.2.1 Global Gabapentin Sales by Region (2021-2026)
  4. 6.2.2 Global Gabapentin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gabapentin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Gabapentin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Gabapentin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Gabapentin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Gabapentin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Gabapentin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Gabapentin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Gabapentin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Gabapentin Revenue by Region
  1. 7.1 Global Gabapentin Revenue by Region
  2. 7.1.1 Global Gabapentin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Gabapentin Revenue by Region (2021-2026)
  4. 7.1.3 Global Gabapentin Revenue by Region (2027-2032)
  5. 7.1.4 Global Gabapentin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Gabapentin Revenue (2021-2032)
  8. 7.2.2 North America Gabapentin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Gabapentin Revenue (2021-2032)
  11. 7.3.2 Europe Gabapentin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Gabapentin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Gabapentin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Gabapentin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Gabapentin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer
  2. 8.1.1 Pfizer Company Information
  3. 8.1.2 Pfizer Business Overview
  4. 8.1.3 Pfizer Gabapentin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Gabapentin Product Portfolio
  6. 8.1.5 Pfizer Recent Developments
  7. 8.2 Assertio Therapeutics
  8. 8.2.1 Assertio Therapeutics Company Information
  9. 8.2.2 Assertio Therapeutics Business Overview
  10. 8.2.3 Assertio Therapeutics Gabapentin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Assertio Therapeutics Gabapentin Product Portfolio
  12. 8.2.5 Assertio Therapeutics Recent Developments
  13. 8.3 TEVA
  14. 8.3.1 TEVA Company Information
  15. 8.3.2 TEVA Business Overview
  16. 8.3.3 TEVA Gabapentin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 TEVA Gabapentin Product Portfolio
  18. 8.3.5 TEVA Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Gabapentin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Gabapentin Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Arbor Pharma
  26. 8.5.1 Arbor Pharma Company Information
  27. 8.5.2 Arbor Pharma Business Overview
  28. 8.5.3 Arbor Pharma Gabapentin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Arbor Pharma Gabapentin Product Portfolio
  30. 8.5.5 Arbor Pharma Recent Developments
  31. 8.6 Novartis
  32. 8.6.1 Novartis Company Information
  33. 8.6.2 Novartis Business Overview
  34. 8.6.3 Novartis Gabapentin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novartis Gabapentin Product Portfolio
  36. 8.6.5 Novartis Recent Developments
  37. 8.7 Apotex
  38. 8.7.1 Apotex Company Information
  39. 8.7.2 Apotex Business Overview
  40. 8.7.3 Apotex Gabapentin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Apotex Gabapentin Product Portfolio
  42. 8.7.5 Apotex Recent Developments
  43. 8.8 Sun Pharmaceutical
  44. 8.8.1 Sun Pharmaceutical Company Information
  45. 8.8.2 Sun Pharmaceutical Business Overview
  46. 8.8.3 Sun Pharmaceutical Gabapentin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sun Pharmaceutical Gabapentin Product Portfolio
  48. 8.8.5 Sun Pharmaceutical Recent Developments
  49. 8.9 Aurobindo Pharma
  50. 8.9.1 Aurobindo Pharma Company Information
  51. 8.9.2 Aurobindo Pharma Business Overview
  52. 8.9.3 Aurobindo Pharma Gabapentin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Aurobindo Pharma Gabapentin Product Portfolio
  54. 8.9.5 Aurobindo Pharma Recent Developments
  55. 8.10 Intas
  56. 8.10.1 Intas Company Information
  57. 8.10.2 Intas Business Overview
  58. 8.10.3 Intas Gabapentin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Intas Gabapentin Product Portfolio
  60. 8.10.5 Intas Recent Developments
  61. 8.11 Amneal
  62. 8.11.1 Amneal Company Information
  63. 8.11.2 Amneal Business Overview
  64. 8.11.3 Amneal Gabapentin Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Amneal Gabapentin Product Portfolio
  66. 8.11.5 Amneal Recent Developments
  67. 8.12 Marksans Pharma
  68. 8.12.1 Marksans Pharma Company Information
  69. 8.12.2 Marksans Pharma Business Overview
  70. 8.12.3 Marksans Pharma Gabapentin Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Marksans Pharma Gabapentin Product Portfolio
  72. 8.12.5 Marksans Pharma Recent Developments
  73. 8.13 Glenmark
  74. 8.13.1 Glenmark Company Information
  75. 8.13.2 Glenmark Business Overview
  76. 8.13.3 Glenmark Gabapentin Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Glenmark Gabapentin Product Portfolio
  78. 8.13.5 Glenmark Recent Developments
  79. 8.14 Alkem
  80. 8.14.1 Alkem Company Information
  81. 8.14.2 Alkem Business Overview
  82. 8.14.3 Alkem Gabapentin Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Alkem Gabapentin Product Portfolio
  84. 8.14.5 Alkem Recent Developments
  85. 8.15 Jiangsu Enhua
  86. 8.15.1 Jiangsu Enhua Company Information
  87. 8.15.2 Jiangsu Enhua Business Overview
  88. 8.15.3 Jiangsu Enhua Gabapentin Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Jiangsu Enhua Gabapentin Product Portfolio
  90. 8.15.5 Jiangsu Enhua Recent Developments
  91. 8.16 Jiangsu Hengrui
  92. 8.16.1 Jiangsu Hengrui Company Information
  93. 8.16.2 Jiangsu Hengrui Business Overview
  94. 8.16.3 Jiangsu Hengrui Gabapentin Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Jiangsu Hengrui Gabapentin Product Portfolio
  96. 8.16.5 Jiangsu Hengrui Recent Developments
  97. 8.17 Sailike
  98. 8.17.1 Sailike Company Information
  99. 8.17.2 Sailike Business Overview
  100. 8.17.3 Sailike Gabapentin Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Sailike Gabapentin Product Portfolio
  102. 8.17.5 Sailike Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gabapentin Value Chain Analysis
  2. 9.1.1 Gabapentin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gabapentin Production Mode & Process
  6. 9.2 Gabapentin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gabapentin Distributors
  9. 9.2.3 Gabapentin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst